Adherence to thalidomide in patients with multiple myeloma: A cross-sectional study in a Brazilian metropolis.

Lívia Pena Silveira Cristiane Aparecida Menezes de PáduaPaula Lana de Miranda DrummondJéssica Soares MaltaRoberta M Marques Dos SantosNaiane Lima CostaTaísa R Lopes MachadoLucas Motta HauckAdriano Max Moreira Reis

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)

Most patients from onco-hematological outpatient clinics in a metropolitan region of southeastern Brazil showed high adherence to thalidomide, which was independently associated with higher income, hospitalization, and higher schooling. More studies are required to understand better the determinants of adherence to thalidomide in the country.

Keyphrases

end stage renal disease
multiple myeloma
newly diagnosed
ejection fraction
physical activity
primary care
chronic kidney disease
prognostic factors
peritoneal dialysis
mental health
type diabetes
patient reported outcomes
patient reported
case control